Cargando…
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220871/ http://dx.doi.org/10.1186/1471-2334-14-S2-O6 |
| _version_ | 1782342798196867072 |
|---|---|
| author | Caruso, Arnaldo Iaria, Marialuisa Caccuri, Francesca Giagulli, Cinzia Fiorentini, Simona |
| author_facet | Caruso, Arnaldo Iaria, Marialuisa Caccuri, Francesca Giagulli, Cinzia Fiorentini, Simona |
| author_sort | Caruso, Arnaldo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4220871 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42208712014-11-10 Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study Caruso, Arnaldo Iaria, Marialuisa Caccuri, Francesca Giagulli, Cinzia Fiorentini, Simona BMC Infect Dis Oral Presentation BioMed Central 2014-05-23 /pmc/articles/PMC4220871/ http://dx.doi.org/10.1186/1471-2334-14-S2-O6 Text en Copyright © 2014 Caruso et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Caruso, Arnaldo Iaria, Marialuisa Caccuri, Francesca Giagulli, Cinzia Fiorentini, Simona Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study |
| title | Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study |
| title_full | Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study |
| title_fullStr | Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study |
| title_full_unstemmed | Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study |
| title_short | Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study |
| title_sort | synthetic hiv-1 matrix protein p17-based at20-klh therapeutic immunization in hiv-1-infected patients receiving antiretroviral treatment: a phase i safety and immunogenicity study |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220871/ http://dx.doi.org/10.1186/1471-2334-14-S2-O6 |
| work_keys_str_mv | AT carusoarnaldo synthetichiv1matrixproteinp17basedat20klhtherapeuticimmunizationinhiv1infectedpatientsreceivingantiretroviraltreatmentaphaseisafetyandimmunogenicitystudy AT iariamarialuisa synthetichiv1matrixproteinp17basedat20klhtherapeuticimmunizationinhiv1infectedpatientsreceivingantiretroviraltreatmentaphaseisafetyandimmunogenicitystudy AT caccurifrancesca synthetichiv1matrixproteinp17basedat20klhtherapeuticimmunizationinhiv1infectedpatientsreceivingantiretroviraltreatmentaphaseisafetyandimmunogenicitystudy AT giagullicinzia synthetichiv1matrixproteinp17basedat20klhtherapeuticimmunizationinhiv1infectedpatientsreceivingantiretroviraltreatmentaphaseisafetyandimmunogenicitystudy AT fiorentinisimona synthetichiv1matrixproteinp17basedat20klhtherapeuticimmunizationinhiv1infectedpatientsreceivingantiretroviraltreatmentaphaseisafetyandimmunogenicitystudy |